Board MeetingOutcome of Board Meeting
Mono Pharmacare's board approved FY26 consolidated financial results, with revenue at ₹168.34 Cr and profit at ₹3.09 Cr.
Mono Pharmacare LimitedMONOPHARMA · Filed with the exchange
The board also appointed internal auditors and re-appointed secretarial auditors, while noting the CS's resignation.
No comments yet. Be the first.